Mega Lifesciences Public Company Limited

SET:MEGA 株式レポート

時価総額:฿33.6b

Mega Lifesciences 過去の業績

過去 基準チェック /36

Mega Lifesciences has been growing earnings at an average annual rate of 13.2%, while the Pharmaceuticals industry saw earnings growing at 10.3% annually. Revenues have been growing at an average rate of 8.2% per year. Mega Lifesciences's return on equity is 20.4%, and it has net margins of 12.7%.

主要情報

13.2%

収益成長率

13.1%

EPS成長率

Pharmaceuticals 業界の成長12.4%
収益成長率8.2%
株主資本利益率20.4%
ネット・マージン12.7%
次回の業績アップデート12 Nov 2024

最近の業績更新

Recent updates

収支内訳

Mega Lifesciences の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。


収益と収入の歴史

SET:MEGA 収益、費用、利益 ( )THB Millions
日付収益収益G+A経費研究開発費
30 Jun 2415,6851,9994,3310
31 Mar 2415,7182,0174,2300
31 Dec 2315,7161,9934,1910
30 Sep 2315,4421,9194,2780
30 Jun 2315,6932,0424,3520
31 Mar 2315,6342,0814,3980
31 Dec 2215,7272,2424,3590
30 Sep 2215,1162,3384,0680
30 Jun 2215,0612,2924,0540
31 Mar 2214,7242,2273,9240
31 Dec 2114,1721,9473,7690
30 Sep 2114,3951,8783,7670
30 Jun 2113,7751,6073,5380
31 Mar 2112,8091,4063,3310
31 Dec 2012,6131,3933,2880
30 Sep 2012,1681,3483,1690
30 Jun 2011,6421,2883,1370
31 Mar 2011,6551,2053,1950
31 Dec 1911,1641,1393,1760
30 Sep 1910,9501,1633,1980
30 Jun 1910,7121,1363,1530
31 Mar 1910,5691,2033,1130
31 Dec 1810,2841,2063,0520
30 Sep 1810,1471,1833,0410
30 Jun 189,9371,1753,0100
31 Mar 189,8291,1782,9880
31 Dec 179,6241,1132,9650
30 Sep 179,5141,0232,9280
30 Jun 179,2829452,8690
31 Mar 178,9688732,7660
31 Dec 168,8287952,6740
30 Sep 168,5147712,6030
30 Jun 168,2267562,6580
31 Mar 168,1157032,7140
31 Dec 157,9666962,7180
30 Sep 157,7756752,6680
30 Jun 157,8626342,5800
31 Mar 157,8515982,4860
31 Dec 147,7495482,4710
30 Sep 147,6204742,4540
30 Jun 147,4225162,3620
31 Mar 147,2265672,3040
31 Dec 137,0556242,2360

質の高い収益: MEGA has high quality earnings.

利益率の向上: MEGA's current net profit margins (12.7%) are lower than last year (13%).


フリー・キャッシュフローと収益の比較


過去の収益成長分析

収益動向: MEGA's earnings have grown by 13.2% per year over the past 5 years.

成長の加速: MEGA's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

収益対業界: MEGA had negative earnings growth (-2.1%) over the past year, making it difficult to compare to the Pharmaceuticals industry average (7.1%).


株主資本利益率

高いROE: MEGA's Return on Equity (20.4%) is considered high.


総資産利益率


使用総資本利益率


過去の好業績企業の発掘